When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Anti-asthmatic agent - Wikipedia

   en.wikipedia.org/wiki/Anti-asthmatic_agent

   An anti-asthmatic agent, also known as an anti-asthma drug, refers to a drug that can aid in airway smooth muscle dilation to allow normal breathing during an asthma attack or reduce inflammation on the airway to decrease airway resistance for asthmatic patients, or both. The goal of asthmatic agents is to reduce asthma exacerbation frequencies ...

3. If You're Living With Asthma, Here's Every Single Treatment ...

   www.aol.com/youre-living-asthma-heres-every...

   Treatment for exercise-induced asthma is similar to other forms of the condition; the main difference is that you will take your medication before exercising as a preventive measure.

4. Bronchial thermoplasty - Wikipedia

   en.wikipedia.org/wiki/Bronchial_Thermoplasty

   In a clinical study, bronchial thermoplasty has been proven to provide long-term reduction in asthma induced breathing difficulty to at least 5 years and improve the quality of life for severe persistent asthma patients. [7] Reduction in asthma attacks, ER visits, and hospitalizations for respiratory symptoms are maintained to at least 5 years ...

5. Long-acting beta-adrenoceptor agonist - Wikipedia

   en.wikipedia.org/wiki/Long-acting_beta...

   LABAs are designed to reduce the need for shorter-acting β 2 agonists such as salbutamol (albuterol), as they have an approximately twelve-hour duration of action, compared to about five hours for salbutamol, making them candidates for sparing high doses of corticosteroids [citation needed] or treating nocturnal asthma and providing ...

6. Zafirlukast - Wikipedia

   en.wikipedia.org/wiki/Zafirlukast

   Zafirlukast is FDA-approved for the prevention and treatment of asthma in adults and children older than 5 years old. [1] Like other leukotriene receptor antagonists, zafirlukast is thought to be useful for the long-term treatment of asthma, but it is generally less effective than inhaled glucocorticoids as monotherapy (which are the standard of care) or long-acting beta-2 agonists in ...

7. Discovery and development of beta2 agonists - Wikipedia

   en.wikipedia.org/wiki/Discovery_and_development...

   This long duration of action made the treatment for severe asthma and COPD more convenient for the patients because it is inhaled twice a day. [1] In 2013 an extra long-acting β 2-agonist, vilanterol, was marketed. Its duration of action lasts for 24 hours which should improve patients' compliance and make the treatment more convenient. [2]